Literature DB >> 15954190

Elevated levels of schizotypal features in parents of patients with a family history of schizophrenia spectrum disorders.

Melanie C M Appels1, Margriet M Sitskoorn, Meinte G Vollema, René S Kahn.   

Abstract

There is some evidence that schizotypal traits are related to a genetic or familial liability to develop schizophrenia. However, it is unclear whether the number of schizotypal traits is elevated in parents of schizophrenia patients compared with controls. This study used the Schizotypal Personality Questionnaire to investigate the difference in number of schizotypal traits between both parents of 36 patients with schizophrenia (n = 72 persons) and 26 healthy married control couples (n = 52 persons). Parents of patients had a lower score on the positive dimension of schizotypy than healthy controls. There was no difference on the negative or disorganization dimension between groups. The difference on the positive dimension might have been caused by a difference in response style between parents of patients and controls due to the fact that parents are more familiar with schizophrenia than controls. Of interest, parents with a family history of schizophrenia spectrum disorders had more positive and negative schizotypal traits than parents without a family history of schizophrenia spectrum disorders. Because these two groups of parents differ in only genetic risk, not familiarity with schizophrenia, results suggest that the negative and positive dimension of schizotypy are related to a familial or genetic vulnerability to schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15954190     DOI: 10.1093/oxfordjournals.schbul.a007131

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  9 in total

1.  Schizotypal, schizoid and paranoid characteristics in the biological parents of social anhedonics.

Authors:  Alex S Cohen; Lindsay C Emmerson; Monica C Mann; Courtney B Forbes; Jack J Blanchard
Journal:  Psychiatry Res       Date:  2010-05-08       Impact factor: 3.222

2.  The nature of schizotypy among multigenerational multiplex schizophrenia families.

Authors:  Sarah I Tarbox; Laura Almasy; Raquel E Gur; Vishwajit L Nimgaonkar; Michael F Pogue-Geile
Journal:  J Abnorm Psychol       Date:  2012-01-30

3.  Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Glen P Davis; Michael T Compton; Shuai Wang; Frances R Levin; Carlos Blanco
Journal:  Schizophr Res       Date:  2013-11-05       Impact factor: 4.939

Review 4.  A multivariate perspective on schizotypy and familial association with schizophrenia: a review.

Authors:  Sarah I Tarbox; Michael F Pogue-Geile
Journal:  Clin Psychol Rev       Date:  2011-07-23

5.  Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia.

Authors:  Zainab Delawalla; Deanna M Barch; Jennifer L Fisher Eastep; Emily S Thomason; Melissa J Hanewinkel; Paul A Thompson; John G Csernansky
Journal:  Schizophr Bull       Date:  2006-05-19       Impact factor: 9.306

6.  Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation.

Authors:  Feikje Smeets; Tineke Lataster; Wolfgang Viechtbauer; Philippe Delespaul
Journal:  Schizophr Bull       Date:  2014-09-12       Impact factor: 9.306

Review 7.  Gene-environment interplay between cannabis and psychosis.

Authors:  Cécile Henquet; Marta Di Forti; Paul Morrison; Rebecca Kuepper; Robin M Murray
Journal:  Schizophr Bull       Date:  2008-08-22       Impact factor: 9.306

Review 8.  Genetic Consideration of Schizotypal Traits: A Review.

Authors:  Emma E Walter; Francesca Fernandez; Mollie Snelling; Emma Barkus
Journal:  Front Psychol       Date:  2016-11-15

9.  Schizotypy and personality profiles of Cluster A in a group of schizophrenic patients and their siblings.

Authors:  Maria Chiara Torti; Antonino Buzzanca; Chiara Squarcione; Carla Salerno; Alessia Mirigliani; Fabio Di Fabio; Massimo Biondi
Journal:  BMC Psychiatry       Date:  2013-10-04       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.